Increased mTOR activity was suggested as a mechanism of resistance to IGF-1R inhibition in Ewing's Sarcoma [5] as well as in a case of acquired resistance to HER2 receptor inhibitor lapatinib in breast cancer [33]. Here, IGF1R is linked to breast cancer.